Drug · DIN 02418738
CORIFACT 250
FACTOR XIII CONCENTRATE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 3, 2014; first marketed April 3, 2014.
- Drug Identification Number (DIN)
- 02418738
- Company (DIN owner)
- Csl Behring Canada IncOttawa, Ontario, Canada
- Schedule
- Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Coagulation factor xiii B02BD07
- Class
- Human
- Record last updated
- August 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FACTOR XIII | 250 UNIT | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 24, 2013: NOC 15055New Drug Submission (NDS)